NCT01774266|UnknownDMC
Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer
DEMRAC
Screening and Triage Test for Early Detection of Gastric Cancer
Loading search results
DEMRAC
Screening and Triage Test for Early Detection of Gastric Cancer
Sponsor study identifier
Secondary identifiers
OTHER · CEI-MEDUC
observational
3,000
1 country
1
Study Start
September 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2012
Actual (reported)Study Completion
March 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
In this proposal the investigators aim to develop a commercial kit to be used in primary screening and non-invasive triage for early detection of gastric cancer. This kit will be cost-effective and more accessible to the general population. In addition, the investigators would like to expand our current patent already submitted to INAPI (National Institute for Intellectual Property) and propose royalties to biomedical diagnostic companies for the use of our product at international level.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2012
Date type not reportedThis date has not been verified as actual or estimated.
December 2012
Actual (reported)January 19, 2013
Actual (reported)January 23, 2013
Actual (reported)March 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Early detection of gastric cancer
Increase the frequency of early detection rate of gastric cancer
2 years
Monitoring progression of disease
2 years
Detection of H.pylori and gastric atrophy
2 years
Molina is one of the counties with the highest mortality rate of gastric cancer in Chile. Molina has a population of 40.000 hab mostly rural. Half of the population lives in Molina city and the other half in the suburbs. Molina is located near the Mountain Andes.
3000 population base study from rural area in south of Chile. This is area has one of the highest incidence of gastric cancer in the world (35/100.000).
Hospital Santa Rosa de Molina
Molina, Maule Region, 8320000, Chile
Bernal C, Aguayo F, Villarroel C, Vargas M, Diaz I, Ossandon FJ, Santibanez E, Palma M, Aravena E, Barrientos C, Corvalan AH. Reprimo as a potential biomarker for early detection in gastric cancer. Clin Cancer Res. 2008 Oct 1;14(19):6264-9. doi: 10.1158/1078-0432.CCR-07-4522.
Carrasco G, Corvalan AH. Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer. Gastroenterol Res Pract. 2013;2013:393015. doi: 10.1155/2013/393015. Epub 2013 Jul 29.
Blood and biopsy samples are collected
First Submitted
January 19, 2013
First Posted
January 23, 2013
Study Start
September 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2012
Actual (reported)Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer
Contact the study team to confirm eligibility.
Study Completion
March 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
June 3, 2013
Record last verified: 2013-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: